Instead of replicating all of Bloomberg, Visible Alpha focused on one "killer feature": providing Wall Street consensus for non-standard metrics (e.g., Tesla car deliveries). This single, highly valuable dataset led to a massive acquisition, proving the power of targeted innovation.

Large companies view opportunities representing less than 1-10% of their total revenue as distractions. This creates a "sweet spot" for startups to build significant businesses in areas ignored by giants, turning a distraction into an opportunity.

While competitors burned cash fighting over major hubs, delivery startup Fancy focused on Tier 2 cities. This strategy gave them a local monopoly, leading to far better unit economics and retention. This strong performance was a key factor in their acquisition by GoPuff.

A smaller fund size enables investments in seemingly niche but potentially lucrative sectors, such as software for dental labs. A larger fund would have to pass on such a deal, not because the founder is weak, but because the potential exit isn't large enough to satisfy their fund return model.

Instead of a broad launch, Everflow targeted only mobile affiliate networks—a small market they knew deeply from their previous company. This allowed them to build very specific, high-value features for that ICP, win deals, and establish a strong beachhead before expanding into larger, adjacent markets.

Instead of competing with billion-dollar platforms, use tools like Firecrawl to build hyper-specialized solutions for a single vertical (e.g., SEO for dentists, job boards for AI engineers). These focused products can win by offering superior relevance and solving one user's problem perfectly.

Despite the dominance of large AI labs, they face constraints in compute, talent, and focus. Startups can thrive by building highly specialized products for verticals the big players deem too niche. This focused approach allows them to build better interfaces and achieve deeper market penetration where giants won't prioritize competing.

Well-funded startups are pressured by investors to target large markets. This strategic constraint allows bootstrapped founders to outmaneuver them by focusing on and dominating a specific niche that is too small for the venture-backed competitor to justify.

A small nonprofit like MedShadow avoids competing with giants like WebMD on volume. Instead, it focuses on a deep, investigative niche—uncovering concealed information about prescription drugs—to attract a dedicated audience that values rigor over quantity.